News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
In today’s fast-evolving biotech landscape, choosing the right biotech CRO (Contract Research Organization) can be the single most...
[Sofia, Bulgaria] – Comac Medical is pleased to announce that Steve Angus will be joining Comac Medical as...
Summer brings sunlit days, long evenings, and countless opportunities to enjoy the outdoors. Yet for the pharmaceutical and...